# Newborn Blood Banking, Inc. – FDA Inspection, Jun 11, 2013

Source: https://www.keypedia.com/records/fda_inspections/newborn-blood-banking-inc/a8f4f483-bcc7-41b4-84eb-05436b28c3db
Source feed: FDA_Inspections

> FDA inspection 834831 of Newborn Blood Banking, Inc., June 11, 2013. Classification: Official Action Indicated (OAI). 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 834831
- Company Name: Newborn Blood Banking, Inc.
- Inspection Date: 2013-06-11
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 626085 - 2009-10-28](https://www.keypedia.com/records/fda_inspections/newborn-blood-banking-inc/a6479131-5f06-44c9-ac4a-c7eafb47d4d8)

Company: https://www.keypedia.com/companies/newborn-blood-banking-inc/446c3595-9169-429b-93e9-0622aa2a81c5

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d